The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA

Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA

July 15, 2017 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Data indicate that patients with RA tend to accumulate many more episodes of heart failure and have a higher risk of mortality following heart failure than do patients without RA.

Data indicate that patients with RA tend to accumulate many more episodes of heart failure and have a higher risk of mortality following heart failure than do patients without RA.
Africa Studio/shutterstock.com

CHICAGO—Sherine E. Gabriel, MD, MSc, professor of medicine at Rutgers Medical School in Newark, N.J., and a past president of the ACR, presented an overview of cardiovascular disease and rheumatology on a Saturday morning to a room overflowing with rheumatologists attending the ACR’s State-of-the-Art Clinical Symposium in April. She noted that physicians have known for a long time that patients with rheumatoid arthritis (RA) have significantly increased overall mortality compared with non-RA patients. In particular, poorer cardiovascular survival in patients with RA compared with non-RA patients appears to account for most of the increased mortality associated with RA. Even though cardiologists have been able to decrease mortality in non-RA patients, people with RA have not benefitted from those breakthroughs.

You Might Also Like
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus
  • Cardiovascular Disease Risk High in RA Patients
  • Lymphoma Risk in RA Patients Remains Steady
Explore This Issue
July 2017
Also By This Author
  • Distinct Autoantigens Found in Patients with Scleroderma & Coincident Cancer

“Now, however, things are starting to change,” explained Dr. Gabriel. This may be because rheumatologists have become successful at achieving tighter immunological control in patients with RA and have thereby improved the treatment of RA and also its comorbidities.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Heart Disease & Failure in RA Today

Dr. Gabriel acknowledged, “The news is not all entirely good, though. … We still see people with rheumatoid arthritis having higher mortality.” Unfortunately, even at the time of diagnosis of RA, patients with RA are at a threefold higher risk of having been hospitalized for a myocardial infarction than patients without RA. Interestingly, however, they are approximately half as likely to present with angina pectoris. This suggests that ischemic heart disease precedes RA and is often silent in this patient population. In addition, patients with RA are approximately one-and-a-half times more likely to die after a myocardial infarction than are patients without RA. This difference is true even though patients with RA are just as likely as patients without RA to be treated aggressively by acute reperfusion therapy and/or be prescribed cardiovascular medications.

Heart failure in patients with RA has been less well studied than ischemic heart disease. That said, the data indicate that patients with RA tend to accumulate many more episodes of heart failure and have a higher risk of mortality following heart failure than do patients without RA. This is true even after adjustments for age and sex, suggesting that the increased cardiovascular risk stems organically from RA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Patients with RA and heart failure also have a higher rate of hospitalization and longer hospital stays than heart failure patients without RA. In addition, in patients with RA, the heart failure tends to happen with preserved ejection fraction, suggesting that not only is the presentation of heart failure different in this patient population, but the nature of the cardiovascular disease is different.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: 2017 State of the Art Clinical Symposium, AC&R, American College of Rheumatology, cardiovascular, mortality, patient care, Research, Rheumatic Disease, Rheumatoid arthritis, rheumatology, riskIssue: July 2017

You Might Also Like:
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus
  • Cardiovascular Disease Risk High in RA Patients
  • Lymphoma Risk in RA Patients Remains Steady
  • Depression May Increase Risk of Cardiovascular Disease for RA Patients

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.